© Borgis - Medycyna Rodzinna 4, p. 70-74
Anna Górkiewicz-Petkow, *Olga Michałowska, Lew Petkow
Świerzb – problemy diagnostyczne i terapeutyczne
Scabies – diagnostic and therapeutic problems
Klinika Dermatologiczna Warszawskiego Uniwersytetu Medycznego, Szpital Kliniczny Dzieciątka Jezus, Centrum Leczenia Obrażeń
Kierownik Kliniki: prof. dr hab. med. Wiesław Gliński
Summary
Scabies is contagious disease of people and animals. Human scabies is caused by the mite Sarcoptes scabiei var hominis, which usually is transmitted from person to person or less often by objects. Infestations occur all over the world and spread easily because of longer average human lifespan, often used immunosupresion, many cases of diseases with decreased immunity
(cancers, HIV infections) and anti-scabies drugs resistance. The proper diagnosis of ectoparasitic skin infections is of great importance for doctors and nurses due to possibilities of spreading of the infection in the society. The problem are endemic sites in the resting houses for elderly people, hospitals, schools.
Clinical picture of scabies is very often not typical, especially in the growing number of cases of hyperkeratotic scabies. Proper diagnosis is also difficult because of difftrent diseases which may coexist with scabies like disseminated eczema, atopic dermatitis, drug eruptions, eythroderma. Choice of treatment depends on symptoms of scabies, coexisting diseases, general health condition, immunosupresive treatment and also economic status of the patient. In case of secondary infections it is important to use topical antiseptic treatment or antibiotics and in case of intensive pruritus antihistamine drugs. Only the proper choice of treatment for the individual case can stop spreading this very contagious disease in the community. The reason of uneffectve treatment may be not treating all of contacts, reinfection (from undertreated places, not desinfected bedclothes, clothes), secondary lesions (allergy, irritation, superinfection).
Key words: scabies, clinical varieties, hyperkeratotic scabies, ivermectine, pyretryna
Piśmiennictwo
1. Orkin M i wsp.: Scabies and pediculosis, Philadelphia, J.B. Lippincott 1977. 2. Ester SA: The diagnosis and management of scabies, In Reed and Carrnick 1988. 3. Andersen B et al.: Outbreak of scabies in Norwegia nursing homes and home care patients: control and prevention, J Hosp Infect 2000; 45: 160-4. 4. Burkhart CG, Burkhart CN, Burkhart KM: An epidemiologic and therapeuticreassesment of scabies, Cutis 2000 Apr; 65(4): 233-40. 5. Talanin NY et al.: Cutaneous histicytosis with Langerhans cell features induced by scabies: a case report, Pediatric Dermatol 1994; 11: 327-30. 6. Bhawan J et al.: Scabies presenting as bullous pemphigoid-like eruption, J Am Acad Dermatol 1991; 24: 179-81. 7. Judge MR, Kobza-Black A: Crusted scabies in pregnancy, Br J Dermatol 1995; 132: 116-9. 8. Hashimoto K et al.: Lesson of the week: Norwegian scabies misdiagnosed as an adverse drug reaction, BMJ 2000; 320: 35-6. 9. Marliere V et al.: Crusted (Norwegia) scabies induced by use of topical corticosteroids and treated successfully with invermection, J Pediatr 1999; 135: 122-4. 10. Gach JE, Heagerty A: Crusted scabies looking like psoriasis, Lancet 2000; 356: 650. 11. Sterling GB, Janniger CK, Kihiczak G: Neonatal scabies, Cutis 1990; 45: 229-31. 12. Meinking TL, Taplin D: Safety of permethrin vs lindane for the treatment of scabies, Arch Dermatol 1996; 132: 959-62. 13. Rasmussen JE: Lindane: a procent approach, Arch Dermatol 1987; 123: 1008-10. 14. Haustein UF, Hlawa B: Treatment of scabies with permethrin versus lindane and benzyl benzoate, Acta Derm Venereol 1989; 69: 3478-351. 15. Nordt SP, Chew G: Acute lindane poisoning in three children, J Emerg Med 2000; 18: 51-3. 16. Taplin D et al.: Comparison of crotamition 10% carem (Eurax) and permethrin 5% carem (Elimite) for the treatment of scabies in children, Pediatr Dermatol 1990; 7: 67-73. 17. Dourmishev A, Serafimova D, Dourmishev L: Efficacy and tolerance of oral invermection in scabies, J Eur Acad Dermatol Venereol 1998; 11: 247-51. 18. Alberici F et al.: Ivermectin alone or in combination with benzyl benzoate in the treatment of human immunodeficiency virus-associated scabies, Br J Dermatol 2000; 142: 969-72. 19. Dannaoui E et al.: Use of ivermectin for the management of scabies in a nursing home, Eur J Dermatol 1999; 9: 443-5. 20. Zalewska A, Janusz J: Zastosowanie doustne iwermektyny w leczeniu świerzbu, Przegl Dermatol 2003; 2: 121-3.
otrzymano/received: 2009-07-30
zaakceptowano/accepted: 2009-08-12
Adres/address:
*Olga Michałowska
ul. Św. Wincenta 112 m. 233, 03-291 Warszawa
tel.: 0 609 741 140
e-mail: dawis@op.pl
